Julia Trosman, PhD, MBA, is co-founder and co-director of the Center for Business Models in Healthcare, a health services research organization focused on personalized care models and precision medicine in oncology. She holds adjunct faculty appointments at the University of California, San Francisco (UCSF) School of Pharmacy, and the Feinberg School of Medicine at Northwestern University.
Dr. Trosman’s work is focused on developing and implementing personalized oncology care delivery models and related reimbursement structures that address challenges of team-based care, timely and coordinated care delivery, and patient engagement. She is one of the authors of the 4R in Oncology Model developed jointly with Northwestern University. Dr. Trosman leads a number of studies and implementation projects of the 4R Model with cancer centers across the U.S.
In collaboration with the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), Dr. Trosman studies adoption and reimbursement of precision medicine, with the current emphasis on healthcare system and reimbursement policy implications of genomic sequencing, including comprehensive tumor profiling and hereditary cancer testing. In collaboration with ECOG-ACRIN, Dr. Trosman leads a study of cancer biomarker testing practices (including next generation sequencing) in the community setting across the U.S.
Dr. Trosman holds an MBA from Kellogg School of Management, Northwestern University, and a PhD in systems engineering from the Law and Economics Institute in Russia.